Those active about 2.5 hours a week had 25 percent lower disease risk than those who weren't, study found
Because it's winter in Brazil, mosquito activity has subsided
Don’t be fooled by the health halo that hangs over seemingly good-for-you foods. Many of them are anything but.
Large study should allay fears that procedure might play a role, researchers say
Researcher calls delay a 'lost opportunity' for treatment
By Elaine Lies and Kwiyeon Ha SAGAMIHARA, Japan (Reuters) - A knife-wielding man broke into a facility for the disabled in a small town near Tokyo early on Tuesday and killed 19 patients as they slept, authorities said, Japan's worst mass killing in decades. At least 25 other residents were wounded in the attack at the Tsukui Yamayuri-En facility in Sagamihara town, about 25 miles (40 km) southwest of Tokyo. "This is a very heart-wrenching and shocking incident in which many innocent people became victims," Chief Cabinet Secretary Yoshihide Suga told a regular news conference in Tokyo.
(Reuters) - Eli Lilly and Co reported better-than-expected quarterly sales, driven by demand for its newer treatments for diabetes and cancer. Revenue rose 8.6 percent to $5.4 billion in the second quarter, topping Wall Street estimates of $5.15 billion, as demand increased for its drugs including Trulicity, Cyramza and Humalog. Lilly resumed earnings growth last year after three years of tumbling sales due to weak demand for its key products amid competition from generic products. The 140-year-old U.S. drugmaker said its net income rose 24.5 percent to $747. ...